ATHIRA PHARMA INC. - COMMON STOCK
0.4000
28-2月-25 10:42:24
15 分の遅延
株式
-0.0226
-5.35%
本日の幅
0.3901 - 0.4138
ISIN
N/A
ソース
NASDAQ
-
08 2 2024 16:02:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
08 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
12 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
29 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
28 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
09 11 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Jefferies London Healthcare Conference
08 11 2023 07:00:02 提供 Nasdaq GlobeNewswire
-
05 10 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming October Conferences
28 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
19 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
10 8 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
06 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming June Conferences
31 5 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
22 5 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports First Quarter 2023 Financial Results and Recent Pipeline and Business Updates
11 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming May Investor Conferences
08 5 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
25 4 2023 16:01:00 提供 Nasdaq GlobeNewswire